Found 5 matching trials
PET Imaging Study to Evaluate the mGlu5r Occupancy Following ADX48621 (Dipraglurant) Administration
PHASE1This is an open label study, non-randomized, positron emission tomography (...
Location
Johns Hopkins Hospital
ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
PHASE2The primary objective of the study is to evaluate the safety and tolerabili...
Location
Addex Investigator Site
Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm
PHASE2This study is designed to assess the safety and tolerability of dipragluran...
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
PHASE2This study is designed to evaluate the safety and efficacy of dipraglurant ...
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
PHASE2This open-label study is designed to assess the long-term safety and tolera...
Location
Augusta University